find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
59
Clinical Trials
Lymphoma
N/A
Enrolling
nct/study# N/A / 2021-0512
Clinical Efficacy and Mechanisms of Resistance to Polatuzumab Vedotin in Patients with Large B-cell Lymphoma After CAR T-cell therapy
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / 2021-0513
Outcomes of patients with aggressive B-cell non-Hodgkin s lymphoma who undergo hematopoietic cell transplantation after CAR T-cell therapy
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / 2021-0552
Outcomes of patients with T-cell lymphoma with central nervous system relapse
Learn More
Lymphoma
Phase II
Enrolling
nct/study# NCT05910801 / ACCRU-LY-2101
Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): A Phase II Study with Safety Lead-in
Learn More
Lymphoma
N/A
Enrolling
nct/study# NCT06500273 / ALLO-501A-202
A randomized, open-label study evaluating the efficacy and safety of cemacabtagene ansegedleucel in participants with minimal residual disease after response to first line therapy for large B-cell lymphoma ALPHA3)
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / BURKITT-LYMPHOMA
Outcomes among Adult Recipients of CAR T-Cell Therapeutics for Burkitt and Burkitt-like Lymphoma
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.